Welcome to the ValueWiki ADHEREX TECHNOLOGIES INC. J (AHX:CA) article! Register for free or click the "edit" link to contribute!

ADHEREX TECHNOLOGIES INC. J (AHX:CA)

From ValueWiki

Jump to: navigation, search

Launch Chat Window

TSX \ Life Sciences \ Biotechnology & Pharmaceuticals

ADHEREX TECHNOLOGIES INC. is a biopharmaceutical company with a focus on cancer therapeutics and a Cadherin targeting platform.Summary from Toronto Stock Exchange

1 Company Analysis
2 News Feed
3 Risks
4 Research Links
5 Notes

Today

Max

[edit]

Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.^[1] Be bold!

[edit]

News Feed

08/13/08 7:08 am	Adherex Reports Second Quarter 2008 Financial Results (CCNMatthews)
06/02/08 7:06 am	Adherex Announces Updated ADH-1 Chemotherapy Combination Data in Melanoma (CCNMatthews)
05/19/08 7:05 am	Adherex Announces ASCO Abstract of ADH-1 in Melanoma (CCNMatthews)
05/15/08 7:05 am	Adherex Announces Publication of ADH-1 Study in Cancer Research (CCNMatthews)
05/14/08 7:05 am	Adherex Announces Agreement for STS Phase III Data (CCNMatthews)
05/13/08 8:05 am	Adherex Reports First Quarter 2008 Financial Results (CCNMatthews)
03/28/08 7:03 am	Adherex Reports 2007 Fiscal Results (CCNMatthews)
03/26/08 5:03 am	Adherex Announces Phase III Trial With STS in Collaboration With the Children's Oncology Group (CCNMatthews)
03/20/08 7:03 am	Adherex to Present ADH-1 Phase I/II Melanoma Trial Data at the 2008 Annual Meeting of the American Society Of Clinical Oncology (ASCO) (CCNMatthews)
02/22/08 8:02 am	Adherex Receives Orphan Drug Designation for ADH-1 in Melanoma (CCNMatthews)